Skip to main content
SpringerLink
Log in

Preimplantation genetic testing reduces IVF-related costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Neal SA, et al. Preimplantation genetic testing for aneuploidy is cost-effective, shortens treatment time, and reduces the risk of failed embryo transfer and clinical miscarriage. Fertility and Sterility 110: 896-904, No. 5, Oct 2018. Available from: URL: http://doi.org/10.1016/j.fertnstert.2018.06.021

    Article  PubMed  Google Scholar 

  2. Robins JC, et al. Preimplantation genetic testing for aneuploidy: costly or cost effective? Fertility and Sterility 110: 851, No. 5, Oct 2018. Available from: URL: http://doi.org/10.1016/j.fertnstert.2018.08.025

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Preimplantation genetic testing reduces IVF-related costs. PharmacoEcon Outcomes News 815, 26 (2018). https://doi.org/10.1007/s40274-018-5407-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5407-z

Search

Navigation